| Financial Year |
March 31 2023 |
| Monetary Funds |
738,612,209.49 |
| Held-for-trading Financial Assets |
232,123,555.74 |
| Notes Receivable |
683,607,739.40 |
| Accounts Receivable |
1,352,713,351.44 |
| Advances to Suppliers |
58,357,503.45 |
| Other Receivables |
27,369,678.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,355,391,107.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,503,387.88 |
| Total Current Assets |
4,460,061,931.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,632,540.75 |
| Investment Properties |
-- |
| Fixed Assetes |
2,829,971,192.65 |
| Under-construction Projects |
444,397,044.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
338,125,559.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,488,494.39 |
| Other Non-Current Assets |
360,847.51 |
| Sub-Total of Non-Current Assets |
3,654,896,303.59 |
| Total Assets |
8,114,958,235.26 |
| Short-Term Loans |
757,199,446.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
737,085,436.07 |
| Accounts Payable |
588,846,229.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,247,110.93 |
| Taxes Payable |
35,202,027.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
27,311,724.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,638,639.00 |
| Other Current Liabilities |
3,591,218.39 |
| Sub-Total of Current Liabilities |
2,189,746,588.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
42,450,815.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
172,620,284.64 |
| Total Liabilities |
2,362,366,873.61 |
| Paid-In Capital(Or Share Stock) |
1,139,457,178.00 |
| Capital Surplus |
1,477,559,504.44 |
| Surplus Reserve |
295,273,419.99 |
| LESS:Treasury Stock |
95,494,972.51 |
| Undistributed Profits |
2,913,765,047.18 |
| Minority Stockholder's Interest |
22,159,227.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,730,432,133.73 |
| Owner's Equity（Stockholder's Equity） |
5,752,591,361.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,114,958,235.26 |
